Patients will have to draw the medication from a syringe, similar to what people who take compounded weight management drugs have to do. The vials are a cheaper alternative for people who don’t have health insurance,

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

Eli Lilly & Co.’s blockbuster obesity shot Zepbound helped people with type 1 diabetes lose more than a fifth of their body weight over a yearlong study, suggesting the drug may help patients with the less common autoimmune form of the disease.

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced higher rates of side effects like nausea and vomiting.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

Results from 4 studies revealed that women lost more weight on average than men when taking tirzepatide — but they also reported more side effects.